De-Risk Early or Pay Later Candidate selection is one of the costliest decisions in drug development. See how INDiGO-Select surfaces DMPK, safety and developability risks early, and how INDiGO takes a confirmed candidate to IND with one integrated team. scox Thu, 10/01/2026 - 13:34 Should your lead candidate be stopped, reworked or confirmed before you commit to IND-enabling studies? Evotec Resource Type Infographic
CryptoAlerta — análise de criptomoedas e mercado em tempo real